Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses.

Journal of Virological Methods
Michael J CarrWilliam W Hall

Abstract

In early 2008, drug susceptibility surveillance of influenza viruses in Europe revealed that some influenza A viruses (subtype H1N1) circulating during the winter season of 2007 and 2008 were resistant to the neuraminidase inhibitor, oseltamivir. This resistance arises due to a histidine to tyrosine substitution in the neuraminidase active site (H275Y in N1 nomenclature). Current methods to detect this mutation involve an end-point reverse transcription polymerase chain reaction followed by nucleotide sequencing. While accurate, this approach has the limitation of being time-consuming, labour-intensive and expensive. Herein we describe a one-step allelic discrimination assay which rapidly (2h) detects this resistance mutation. The sensitivity of the assay was as low as 10 copies per reaction and is capable of detecting the antiviral resistance mutation in a mixture of wild type H275 and mutant H275Y targets.

References

Oct 21, 1998·The Journal of Infectious Diseases·L V GubarevaR G Webster
Mar 11, 2000·Lancet·L V GubarevaF G Hayden
Feb 15, 2001·The Journal of Infectious Diseases·L V GubarevaF G Hayden
Feb 27, 2001·The Pediatric Infectious Disease Journal·R J WhitleyP Ward
Jun 29, 2001·Antiviral Research·M ZambonUNKNOWN Global Neuraminidase Inhibitor Susceptibility Network
Apr 11, 2003·Vaccine·Arnold S Monto
Jan 13, 2004·Clinical and Diagnostic Laboratory Immunology·James J McSharryGeorge L Drusano
Mar 23, 2004·American Journal of Epidemiology·Ira M LonginiYang Yang
Jun 12, 2004·BMJ : British Medical Journal·Ran D BalicerItamar Grotto
Aug 17, 2004·Journal of Virology·Aleksandr S LipatovRobert G Webster
Oct 13, 2004·The Journal of Infectious Diseases·M Louise HerlocherArnold S Monto
Jan 26, 2005·The New England Journal of Medicine·Arnold S Monto
Jun 2, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·R N GunsonW F Carman
Aug 5, 2005·Science·Ira M LonginiM Elizabeth Halloran
Aug 5, 2005·Nature·Neil M FergusonDonald S Burke
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Hui-Ling YenElena A Govorkova
Sep 30, 2005·The New England Journal of Medicine·Anne Moscona
Feb 4, 2006·JAMA : the Journal of the American Medical Association·Rick A BrightAlexander I Klimov
Apr 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Timothy C GermannCatherine A Macken
Apr 28, 2006·Nature·Neil M FergusonDonald S Burke
Oct 24, 2006·Journal of Virological Methods·Salin ChutinimitkulYong Poovorawan
Oct 18, 2007·Annual Review of Medicine·Anne Moscona
Dec 7, 2007·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Vanessa EscuretOlivier Ferraris
Mar 20, 2008·PloS One·Seyed M MoghadasJianhong Wu

❮ Previous
Next ❯

Citations

Nov 18, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M Redlberger-FritzT Popow-Kraupp
Mar 12, 2010·Journal of Clinical Microbiology·Mami HataHiroko Minagawa
Mar 27, 2009·Journal of Clinical Microbiology·Jennifer M LaplanteKirsten St George
Jun 21, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Christian RenaudJanet A Englund
Sep 18, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·James B MahonyMarek Smieja
Jan 4, 2013·Influenza and Other Respiratory Viruses·Margaret Okomo-AdhiamboLarisa V Gubareva
Mar 9, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J C Rahamat-LangendoenA Riezebos-Brilman
Apr 20, 2013·The Journal of Molecular Diagnostics : JMD·Erhard van der VriesMartin Schutten
Jul 8, 2009·Expert Review of Molecular Diagnostics·Varough M Deyde, Larisa V Gubareva
Sep 15, 2010·Journal of Intensive Care Medicine·Karen Joan VigilRoy F Chemaly
Feb 19, 2010·The Cochrane Database of Systematic Reviews·Tom JeffersonRuth Foxlee
May 12, 2010·Expert Review of Anti-infective Therapy·Ruixue Wang, Jeffery K Taubenberger
Jun 26, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ning LiuZongwei Cai
Jan 1, 2014·Central European Journal of Biology·Dawid NidzworskiBogusław Szewczyk

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.